Combination of Atezolizumab and Pirfenidone in Second-line and Beyond NSCLC
for
NSCLC Stage IV, NSCLC, Recurrent
Location: Kansas City KS
Sponsor: University of Kansas Medical Center
Sex: All
Age: 18+
Code: NCT04467723
Phase1, Phase2, Recruiting
Insomnia in Patients With Metastatic Lung Cancer
for
Metastatic Lung Non-Small Cell Carcinoma,
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT06472804
Recruiting
Ipatasertib and Docetaxel in Metastatic NSCLC Patients Who Have Failed 1st Line Immunotherapy
for
NSCLC Stage IV, NSCLC Stage IIIB
Location: Kansas City KS, Fairway KS
Sponsor: Jun Zhang, MD, PhD
Sex: All
Age: 18+
Code: NCT04467801
Phase2, Recruiting
First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
for
Advanced Solid Tumors, HNSCC, SCLC, NSCLC,
Location: Boston MA, New York NY, New Haven CT, Miami FL, Toronto,
Sponsor: Tubulis GmbH
Sex: All
Age: 18+
Code: NCT06657222
Phase1, Phase2, Recruiting
A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs
for
Lung Cancer, Non-small Cell, Lung Cancer Metastatic,
Location: Weston FL, Canton OH, Cleveland OH, Detroit MI,
Sponsor: Krystal Biotech, Inc.
Sex: All
Age: 18+
Code: NCT06228326
Phase1, Phase2, Recruiting
Interested in new non small cell lung cancer trials?
Get alerts for new trials in your area by subscribing now
Stereotactic Body Radiation Therapy Planning With Artificial Intelligence-Directed Dose Recommendation for Treatment of Primary or Metastatic Lung Tumors, RAD-AI Study
for
Lung Carcinoma, Lung Non-Small Cell Carcinoma,
Location: Chicago IL
Sponsor: Northwestern University
Sex: All
Age: 18+
Code: NCT05802186
Recruiting
Immune Profile Selection By Fraction of ctDNA in Patients With Advanced NSCLC Treated With Immunotherapy
for
Carcinoma, Non-Small-Cell Lung
Location: Hackensack NJ
Sponsor: Hackensack Meridian Health
Sex: All
Age: 18+
Code: NCT05715229
Phase2, Recruiting
A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.